Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age
Clinical trial NCT01621802 · COMPLETED
Trial details
- NCT number
- NCT01621802
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-21
- Primary completion
- 2015-07-06
- Enrollment
- 4011
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.